Legal Representation
Attorney
Dermot Horgan
USPTO Deadlines
Next Deadline
2182 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-07-15)
Due Date
July 15, 2031
Grace Period Ends
January 15, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
17 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 15, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jul 15, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| May 27, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 27, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 21, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 29, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 28, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 28, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Apr 28, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 3, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 3, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 3, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 3, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 3, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 9, 2024 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Dec 9, 2024 | TAEA | I | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | Loading... |
| Nov 29, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Living cells being specialised cells derived from artificially differentiated stem cells for research purposes; living cells being specialised cells derived from artificially differentiated stem cells for scientific purposes; living cells being specialised cells derived from artificially differentiated stem cells other than for medical or veterinary purposes; biological tissue, namely, human tissue for use in scientific and medical research; biological tissue cultures other than for medical or veterinary purposes; cell culture media, other than for medical or veterinary purposes; chemical reagents for use in biotechnology, other than for medical or veterinary use; nutritive agents for processing living cells, namely, nutritive substances for microorganism cultures, other than for medical or veterinary purposes; proteins for use in recombinant DNA technology, other than for medical use; stem cells for research purposes; stem cells for scientific purposes; stem cells other than for medical or veterinary purposes; skeletal myocytes for research purposes; cortical neurons for research purposes; semi-processed natural proteins for manufacturing food; proteins for use in the manufacture of food products
Class 005
Pharmaceuticals in the nature of cell therapeutics for medical, therapeutic or clinical use; cells for medical use, namely, genetically or otherwise modified cells; cells for medical use, namely, cells which are propagated, cultivated and expanded in bioreactors; cells for medical use, namely, cells for tissue regeneration; living cells for medical use; cells for medical use; living cells for veterinary use; biological preparations for use in cell cultures for medical purposes; diagnostic preparations for medical or veterinary purposes; biological preparations for use in cell cultures for medical purposes, namely, drug screening; biological preparations for use in cell cultures for medical purposes, namely, genetic testing and screening; stem cells for medical purposes; stem cells for veterinary purposes; cell growth media for growing cells, biological tissue cultures, protein arrays, namely, cytokines, antibodies, and reagents, all for medical, medical diagnostic, or clinical use; tissue culture media growth factors in the nature of cell growth media for growing cells and nutritional supplements for in vitro culturing, development, maintenance, expansion, assay or manipulation of cells, all for medical or clinical use; biochemical reagents, namely, cell separation reagents for medical purposes; dietary supplements; protein supplements; nutritional supplements
Additional Information
Design Mark
The mark consists of the letter "i" in orange, the letter "o" in blue, and "Cells" in black.
Color Claim
The colors orange, blue, and black are claimed as a feature of the mark.
Pseudo Mark
IO CELLS
Classification
International Classes
001
005